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1 A well-designed early-CEA methodology helps to develop (cost-)effective
medical tests efficiently. (this thesis)
2 If important practice variation or deviation from the clinical guidelines exists, 
the test strategy that is actually provided in hospitals should be compared 
with the new test strategy. (this thesis)
3 Analysis of recent data shows that the hospital costs of ischemic stroke 
have substantially declined in the past 10 years. (this thesis)
4 New tests to diagnose rheumatoid arthritis in inflammatory arthritis patients 
are cost-effective when they are used as an add-on for intermediate-risk patients,
have a high specificity, and cost no more than €200-€300. (this thesis)
5 The value of a confirmatory imaging test strategy to select appropriate treatment
for patients with a recent TIA or minor ischemic stroke is limited when
compared to the guideline-based test strategy. (this thesis)
6 Precision medicine – in some cases, people call it personalized medicine –
gives us one of the greatest opportunities for new medical breakthroughs 
that we have ever seen. (Barack Obama)
7 Medical science has made such tremendous progress that there is hardly 
a healthy human left. (Aldous Huxley)
8 The science of today is the technology of tomorrow. (Edward Teller)
9 Involvement of the different stakeholders in early cost-effectiveness analyses of
medical tests and discussion of the results leads to improved decisions.
10 If we knew what it was we were doing, it would not be called research. 
(Albert Einstein)
11 Every mountain top is within reach if you just keep climbing. (Barry Finlay) 
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